During the Trump administration, certain terms were reportedly discouraged or prohibited from use within specific governmental agencies, particularly the Centers for Disease Control and Prevention (CDC). These terms, including “vulnerable,” “entitlement,” “diversity,” “transgender,” “fetus,” “evidence-based,” and “science-based,” were allegedly identified as words to avoid in budget-related documents. This list, while not officially codified as a ban through legislation, raised concerns regarding potential limitations on scientific communication and data collection.
The reported restriction carried significant implications for public health research, data transparency, and the accurate dissemination of information to the public. By avoiding certain terms, agencies risked obscuring critical aspects of their work, potentially affecting funding allocations, research priorities, and the overall understanding of vital health issues. Furthermore, the directive sparked debate about censorship, political interference in scientific discourse, and the potential erosion of public trust in government institutions.
